Chislock, Elizabeth M.
Pan, Tien-chi
Pant, Dhruv
Chen, Yan
Woodfield, George
Graves, Jewell
Lawrence-Paul, Matthew R.
Belka, George K.
Wang, Jianping
Bayne, Lauren
Blanchard, Tatiana
Smith, Meaghan
Ji, Xiaodan
Shih, Natalie N. C.
Soucier-Ernst, Danielle
Goodman, Noah
Nivar, Isoris
Goodspeed, Brooke
DeLuca, Shannon
Ndicu, John
Clark, Candace
Langer, Melissa
William Stavropoulos, S.
DeMuth, William
Morschauser, Andrew
Murphy, William
Nayak, Anupma
Feldman, Michael
Clark, Amy
Yu, Liping
Judge, Kevin
Bornheimer, Scott
Pletcher, Charles H. Jr.
Moore, Jonni S.
DeMichele, Angela
Chodosh, Lewis A.
Funding for this research was provided by:
National Institutes of Health (CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273, CA208273)
Susan G. Komen (PDF17483333)
Abramson Cancer Center (P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520, P30 CA016520)
Article History
Received: 3 February 2025
Accepted: 27 October 2025
First Online: 24 November 2025
Competing interests
: A.D. has institutional research funding from Novartis, Genentech, Pfizer, and NeoGenomics. L.A.C. has served as an expert consultant to Teva Pharmaceuticals, Eisai, Sanofi, Eli Lilly, Whittaker, Clark and Daniels, Wyeth, Imerys, Colgate, Becton Dickinson, Sterigenics, and the U.S. Department of Justice in litigation. L.Y., K.J., and S.B. are current or former employees of BD. L.Y. and BD are inventors on patents on the technology used in the FACSFocus device. E.M.C. and L.A.C. are inventors on a patent related to the DTC-Flow assay. Other authors declare no competing interests.